Breast cancer cases reported in premenopausal DES Daughters
1996 Study Abstract
Two premenopausal women recently presented to the British Columbia Cancer Agency with a history of intrauterine exposure to stilboestrol (diethylstilboestrol, DES) and newly diagnosed breast cancer.
- The first, age 28, had known DES sequelae with a bicornate uterus and presented with stage IV breast cancer.
- The second, age 34, presented with stage II breast cancer and no previous health problems.
Neither patient had any known familial history of breast cancer, or any other risk factors.
- Premenopausal breast cancer after in-utero exposure to stilboestrol, The Lancet DOI: 10.1016/S0140-6736(96)24031-0, 03 August 1996.
- Featured image Markus Spiske.